A REVIEW OF SODIUM PENTOBARBITAL SOLUBILITY

Contraindicated (1)pentobarbital will minimize the extent or effect of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with solid CYP3A4 inducers may lead to lessened serum concentrations and loss of antimalarial efficacypentobarbital will decrease the level or effect of zolpidem by impacti